BioStock Investor Meeting: Arcede Pharma presents
At the end of June this year, following the spin-off from Respiratorius, trading in Arcede Pharma began on Spotlight. At the helm is CEO Mia Lundblad, who came to the BioStock Investor Meeting to talk about Arcede’s COPD and asthma project RCD45. She also talked about what’s next to come for the company.
Watch Arcede Pharma’s presentation below.
